知镜 Cognispect · 医学文献与研究工作台

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development

Binder ZA, Thorne AH, Bakas S, et al.
Cancer Cell · 2018-07-01 · PMID 29990498

文献摘要

We explored the clinical and pathological impact of epidermal growth factor receptor (EGFR) extracellular domain missense mutations. Retrospective assessment of 260 de novo glioblastoma patients revealed a significant reduction in overall survival of patients having tumors with EGFR mutations at alanine 289 (EGFR A289D/T/V ). Quantitative multi-parametric magnetic resonance imaging analyses indicated increased tumor invasion for EGFR A289D/T/V mutants, corroborated in mice bearing intracranial tumors expressing EGFR A289V and dependent on ERK-mediated expression of matrix metalloproteinase-1. EGFR A289V tumor growth was attenuated with an antibody against a cryptic epitope, based on in silico simulation. The findings of this study indicate a highly invasive phenotype associated with the EGFR A289V mutation in glioblastoma, postulating EGFR A289V as a molecular marker for responsiveness to therapy with EGFR-targeting antibodies.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。